NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Wilhem Leconet
Cornell University - Ithaca / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1295687
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Wilhem Leconet's MOST POPULAR ARTICLES
1-)
Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in salivaTJ Ketas, D Chaturbhuj, VMC Portillo, E Francomano, E Golden, ...Pathogens and Immunity 6 (1), 116, 2021982021
2-)
Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapyW Leconet, C Larbouret, T Chardès, G Thomas, M Neiveyans, M Busson, ...Oncogene 33 (47), 5405-5414, 2014892014
3-)
Therapeutic activity of anti-AXL antibody against triple-negative breast cancer patient-derived xenografts and metastasisW Leconet, M Chentouf, S du Manoir, C Chevalier, A Sirvent, I Aït-Arsa, ...Clinical Cancer Research 23 (11), 2806-2816, 2017902017
4-)
Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pumpT Mazard, A Causse, J Simony, W Leconet, N Vezzio-Vie, A Torro, ...Molecular cancer therapeutics 12 (10), 2121-2134, 2013652013
5-)
Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylationY Lazrek, O Dubreuil, V Garambois, N Gaborit, C Larbouret, ...Neoplasia 15 (3), 335-IN40, 2013522013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept